Navigation Links
Gene Connections Key to Brain Tumor Growth
Date:7/14/2009

Discovery could help change disease from fatal to chronic, researcher says

TUESDAY, July 14 (HealthDay News) -- Researchers have identified a network of mutated genes and gene processes that, together, contribute to the development of glioblastomas, the deadliest type of brain tumor.

"There is not a single gene that accounts for the development of brain tumors," explained Dr. Markus Bredel, co-author of two related papers in the July 15 issue of the Journal of the American Medication Association. "It's the concert of those genes and the interaction of those genes that ultimately determine the progression of cancer."

Bredel, who is director of the Brain Tumor Institute Research Program at Northwestern University's Feinberg School of Medicine in Chicago, proposed that a combination of therapies targeting specific biological events might improve treatment outcomes for this type of cancer. Outcomes have remained stubbornly the same for about three decades.

"We hope that's the future of therapy -- that we can, over the long term, transfer this into a more chronic disease so patients could hopefully live 10 to 15 years," Bredel said. Development of a cure in that time frame is unlikely, he said.

People with glioblastomas now live an average of 12 to 14 months. U.S. Sen. Edward M. Kennedy (D-Mass.) was diagnosed in May 2008 with a malignant brain tumor.

"The authors have really made sense of these genetic changes and identified some of the pathways that seem to be crucial for glioblastoma development," said Dr. Boris Pasche, co-author of an accompanying editorial in the journal and associate director of the Comprehensive Cancer Center at the University of Alabama at Birmingham. "It's very exciting because it holds promise for identification of the Achilles' heel of this disease. If you can target several pathways that are implicated in a given disease, you can effectively change the course of
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. BurrellesLuce White Paper Gives Advice on Turning Twitter Connections Into Community Building Blocks
2. Meaningful Connections Offers Guidance, Case Examples for use of Electronic Health IT to Support Patient Centered Medical Home
3. Seniors Invited to Learn About Fraud Prevention at SCAN Connections Resource Center on April 28
4. American Cancer Society Launches Major Brand Revitalization Effort to Help Broaden Consumer Understanding and Connections
5. B. Brauns DoseTrac(TM) Software: Making Connections to Better Manage IV Therapy
6. Continua Health Alliance to Host Open Meeting at CONNECTIONS(TM) Tuesday, June 24th at 2:30 pm
7. Parks Associates Analysts Present Insights on Broadband, Digital Content, Advertising, Home Systems, and Digital Health at CONNECTIONS(TM)
8. Faulty brain connections may be responsible for social impairments in autism
9. Continua Health Alliance Provides Insight Into Next Generation of Digital Health at CONNECTIONS(TM)
10. Transportation: Making Connections Event to Explore Opportunities and Solutions for People With Disabilities
11. Study: Brain connections strengthen during waking hours, weaken during sleep
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Connections Key to Brain Tumor Growth
(Date:8/20/2014)... August 20, 2014 BuyCheapTicketsToEvents.com is ... wide selection of tickets to many events. Cheap NHL hockey ... begin in September. , Hockey fans are enthusiastic about their ... tickets for games. Now is the time to acquire 2014 ... in mere months. There will be a great deal of ...
(Date:8/20/2014)... people grow older, they often have difficulty falling asleep ... in the morning. In individuals with Alzheimer,s disease, this ... especially pronounced, often leading to nighttime confusion and wandering. ... Israel Deaconess Medical Center (BIDMC) and the University of ... more fragmented with age. Reported online today in the ...
(Date:8/20/2014)... Mixberry Media announced today its new integrated ... a new source of revenue. , The innovative experience ... a narration of their favorite news and articles using ... Users can now multitask: read/write email, drink coffee, get ... , Mixberry Media’s service converts news and ...
(Date:8/20/2014)... Riverside Health System is pleased to ... its Warsaw Medical Arts team earlier this year, bringing ... is accepting new patients. , Dameron, a 2009 graduate ... residency at the Mountain Area Health Education Center in ... really like the rural aspect of [Tappahannock],” Dameron said ...
(Date:8/19/2014)... As moms and dads prepare their children to go ... normal routine of dropping their little ones off at daycare ... encourages them to use the opportunity to implement a ... Yarker explains, “Kids have small tummies, short attention spans, and ... food handouts, use snack time as another daily opportunity to ...
Breaking Medicine News(10 mins):Health News:2014 NHL Preseason Tickets Are Among Top Selling Seats at Trusted Provider BuyCheapTicketsToEvents.com 2Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3Health News:Mixberry Media, First To Offer Article Voice Narration with Integrated Audio Advertising 2Health News:Riverside Warsaw Medical Arts’ Dr. William Dameron Accepting New Patients 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3
... , NEW YORK, Sept. 21 ... the validity of two Minerva Industries, Inc. patents for mobile ... of new evidence which can show Eli Lilly & Company,s ... counsel. The discovery of this patent validity evidence can impact ...
... , ST. LOUIS, Sept. 21 ... Perrigo Company (Nasdaq: PRGO ) of KV,s first-to-file Paragraph ... Drug Administration for a generic equivalent version of GlaxoSmithKline,s Duac(R) gel. ... transaction, KV will receive $14 million from Perrigo at closing and ...
... WASHINGTON, Sept. 21 /EIN News/ According to the Web site ... the Clinton administration Philip Morris "worked off-the-record with . . . ... have been partly funded by a huge increase in tobacco taxes. ... the term "death panels" used by anti-healthcare reform activists determined to ...
... By 2050, 115 million people may suffer from dementia ... Alzheimer,s disease is accelerating at a rapid pace, and by ... from dementia -- a 10 percent increase since 2005, ... double every 20 years, reaching 65.7 million in 2030 and ...
... , , FORT ... Multicultural Communities Survey sponsored by the LACTAID(R) Brand found that ... or dairy in their diet as a way to manage their ... have lactose intolerance worry the condition keeps them from consuming important ...
... , BALTIMORE, Sept. 21 A new ... the recession is contributing to acute, or short-term, physical pain ... Pain Awareness Month, 68 percent of people who experienced acute ... the past year said that the recession caused, increased or ...
Cached Medicine News:Health News:Minerva and Cymbalta Patent Invalidity Evidence Uncovered by Article One Partners Community 2Health News:Minerva and Cymbalta Patent Invalidity Evidence Uncovered by Article One Partners Community 3Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 2Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 3Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 4Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 5Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 6Health News:'Death Panel' Inventor & Critic of Healthcare Reform Betsy McCaughey 'Has Close Ties' to Philip Morris; Healthcare Industry Today Offers Complete Coverage 2Health News:Alzheimer's Soars, Global Focus Needed: Study 2Health News:Alzheimer's Soars, Global Focus Needed: Study 3Health News:New Research Finds Most African American Women with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 2Health News:New Research Finds Most African American Women with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 3Health News:New Research Finds Most African American Women with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 4Health News:Economic Pain Contributing to Acute Physical Pain for Many Americans, New Survey Says 2Health News:Economic Pain Contributing to Acute Physical Pain for Many Americans, New Survey Says 3Health News:Economic Pain Contributing to Acute Physical Pain for Many Americans, New Survey Says 4
(Date:8/19/2014)... 19, 2014  Boehringer Ingelheim today announced that ... for review the New Drug Application (NDA) for ... delivered via the Respimat ® inhaler for ... of airflow obstruction in patients with chronic obstructive ... Tiotropium + olodaterol FDC will not be indicated ...
(Date:8/19/2014)... -- Cardiva Medical, Inc. announced today that it has closed ... 3 private equity financing and a $12.5 million senior ... the proceeds of the Series 3 private equity financing ... VASCADE® Vascular Closure System in the United ... 3 private equity financing was a new investor, Canepa ...
(Date:8/19/2014)... Aug. 19, 2014  Sequence, Inc., an industry leader in ... and medical device manufacturers is opening a third office location ... , as a result of demand by clients to ... opened this month, allows Sequence to better serve new and ... St. Louis office provides Sequence a hub ...
Breaking Medicine Technology:Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2Quality and Compliance Solutions Provider Announces Opening of St. Louis, Missouri Office 2
... FRANCISCO, Calif., June 01, 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, ... from ongoing clinical,studies of SNS-595 and SNS-032 at ... being held June 7-10, 2007 in Vienna,Austria. , ... Phase 1 clinical trial of SNS-595 in acute ...
... Zurich, June 1, 2007-Cytos Biotechnology AG is ... presentations of its novel,immunotherapeutic CYT003-QbG10 to treat ... were obtained,and will be presented in different ... Academy of Allergology and Clinical Immunology,(EAACI), taking ...
Cached Medicine Technology:Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 2Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 3CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007 2
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe....
Bard® Channel Drain...
... Used for stone manipulation ... duct. The nitinol memory wire ... its shape following extreme torsion. ... the likelihood of mucosal damage ...
Used for serial post-operative cholangiography and the placement of a wire guide to facilitate post-operative E.R.C.P. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: